Alimta Lyophilisate For Solution For Injection 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Alimta: Lyophilisate for solution for injection (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PEMETREXED (PEM e TREX ed) is a chemotherapy drug. This medicine affects cells that are rapidly growing, such as cancer cells and cells in your mouth and stomach. It is usually used to treat lung cancers like non-small cell lung cancer and mesothelioma. It may also be used to treat other cancers.

In-Depth Information

Alimta 100mg Powder for Injection

NDC: 000027640
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Mesothelioma

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Gastric Cancer, Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Head And Neck Cancer, Bladder Cancer

Storage Information
Discard product if it contains particulate matter, is cloudy, or discolored
Discard unused portion. Do not store for later use.
Store unreconstituted product at 77 degrees F; excursions permitted to 59-86 degrees F
Alimta 100mg Powder for Injection

Reported Side Effects for Alimta 100mg Powder for Injection

Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Intestinal Blockage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Nerve Pain Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Kidney Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
<8.0%*
Severity: MILD
Onset: EARLY
Throat Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Erythema Multiforme Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Abnormal Heart Rhythm Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Chest Pain Incidence:
<8.0%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Conjunctivitis Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Secretion Of Tears Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
1.0-5.0%*
Severity: MILD
Onset: RAPID
Low Platelet Count Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
1.0-7.0%*
Severity: MILD
Onset: RAPID
Dehydration Incidence:
1.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0-21.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
2.0-15.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
3.0-23.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
3.0-11.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot Incidence:
3.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
3.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
3.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
4.5-10.0%*
Severity: SEVERE
Onset: EARLY
Mouth Ulcers Incidence:
5.0-23.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
5.0-17.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
6.0-57.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
6.0-12.0%*
Severity: MILD
Onset: DELAYED
Mouth Sores Incidence:
7.0-23.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
7.0-16.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
7.0-23.0%*
Severity: MILD
Onset: DELAYED
Metallic Taste Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
12.0-82.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
>19.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
19.0-27.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Alimta

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5